TrialInternational journal of hematology2011

Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia.

Zhenyu Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.